Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1

被引:108
|
作者
Zhang, LQ
He, T
Huang, YX
Chen, ZW
Guo, Y
Wu, S
Kunstman, KJ
Brown, RC
Phair, JP
Neumann, AU
Ho, DD
Wolinsky, SM
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
[2] Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA
[3] Bar Ilan Univ, Dept Life Sci, IL-52900 Ramat Gan, Israel
关键词
D O I
10.1128/JVI.72.11.9307-9312.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We tested chemokine receptor subset usage by diverse, well-characterized primary viruses isolated from peripheral blood by monitoring viral replication with CCR1, CCR2b, CCR3, CCR5, and CXCR4 U87MG.CD4 transformed cell lines and STRL33/BONZO/TYMSTR and GPR15/BOB HOS.CD4 transformed cell lines. primary viruses were isolated from 79 men with confirmed human immunodeficiency virus type 1 (HIV-1) infection from the Chicago component of the Multicenter AIDS Cohort Study at interval time points. Thirty-five additional well-characterized primary viruses representing HIV-1 group M subtypes A, B, C, D, and E and group O and three primary simian immunodeficiency virus (SIV) isolates were also used for these studies. The restricted use of the CCR5 chemokine receptor for viral entry was associated with infection by a virus having a non-syncytium-inducing phenotype and correlated with a reduced rate of disease progression and a prolonged disease-free interval. Conversely, broadening chemokine receptor usage from CCR5 to both CCR5 and CXCR4 was associated with infection by a virus having a syncytium-inducing phenotype and correlated with a faster rate of CD4 T-cell decline and progression of disease. We also observed a greater tendency for infection with a virus having a syncytium-inducing phenotype in men heterozygous for the defective CCR5 Delta 32 allele (25%) than in those men homozygous for the wild-type CCR5 allele (6%) (P = 0.03), The propensity for infection with a virus having a syncytium-inducing phenotype provides a partial explanation for the rapid disease progression among some men heterozygous for the defective CCR5 Delta 32 allele, Furthermore, we did not identify any primary viruses that used CCR3 as an entry cofactor, despite this CC chemokine receptor being expressed on the cell surface at a level commensurate with or higher than that observed for primary peripheral blood mononuclear cells. Whereas isolates of primary viruses of SIV also used STRL33/BONZO/TYMSTR and GPR15/BOB, no primary isolates of HN-P used these particular chemokine receptor-like orphan molecules as entry cofactors, suggesting a limited contribution of these other chemokine receptors to viral evolution, Thus, despite the number of chemokine receptors implicated in viral entry, CCR5 and CXCR4 are likely to be the physiologically relevant chemokine receptors used as entry cofactors in vivo by diverse strains of primary viruses isolated from blood.
引用
收藏
页码:9307 / 9312
页数:6
相关论文
共 50 条
  • [1] Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage
    Cecilia, D
    Kewalramani, VN
    O'Leary, J
    Volsky, B
    Nyambi, P
    Burda, S
    Xu, S
    Littman, DR
    Zolla-Pazner, S
    JOURNAL OF VIROLOGY, 1998, 72 (09) : 6988 - 6996
  • [2] Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
    Bjorndal, A
    Deng, HK
    Jansson, M
    Fiore, JR
    Colognesi, C
    Karlsson, A
    Albert, J
    Scarlatti, G
    Littman, DR
    Fenyo, EM
    JOURNAL OF VIROLOGY, 1997, 71 (10) : 7478 - 7487
  • [3] Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status
    Kreisberg, JF
    Kwa, D
    Schramm, B
    Trautner, V
    Connor, R
    Schuitemaker, H
    Mullins, JI
    van't Wout, AB
    Goldsmith, MA
    JOURNAL OF VIROLOGY, 2001, 75 (18) : 8842 - 8847
  • [4] Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1
    Pöhlmann, S
    Krumbiegel, M
    Kirchhoff, F
    JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 1241 - 1251
  • [5] Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage
    Trkola, A
    Ketas, T
    Kewalramani, VN
    Endorf, F
    Binley, JM
    Katinger, H
    Robinson, J
    Littman, DR
    Moore, JP
    JOURNAL OF VIROLOGY, 1998, 72 (03) : 1876 - 1885
  • [6] Unexpected coreceptor usage of primary human immunodeficiency virus type 1 isolates from viremic patients under highly active antiretroviral therapy
    Holtkamp, N
    Otteken, A
    Findhammer, S
    Miller, V
    Kurth, R
    Werner, A
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02): : 513 - 521
  • [7] Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities
    Guillon, C
    van der Ende, ME
    Boers, PHM
    Gruters, RA
    Schutten, M
    Osterhaus, ADME
    JOURNAL OF VIROLOGY, 1998, 72 (07) : 6260 - 6263
  • [8] Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells
    Zhang, YJ
    Lou, B
    Lal, RB
    Gettie, A
    Marx, PA
    Moore, JP
    JOURNAL OF VIROLOGY, 2000, 74 (15) : 6893 - 6910
  • [9] Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivity
    LaCasse, RA
    Follis, KE
    Moudgil, T
    Trahey, M
    Binley, JM
    Planelles, V
    Zolla-Pazner, S
    Nunberg, JH
    JOURNAL OF VIROLOGY, 1998, 72 (03) : 2491 - 2495
  • [10] A formylpeptide receptor, FPRL1, acts as an efficient coreceptor for primary isolates of human immunodeficiency virus
    Shimizu N.
    Tanaka A.
    Mori T.
    Ohtsuki T.
    Hoque A.
    Jinno-Oue A.
    Apichartpiyakul C.
    Kusagawa S.
    Takebe Y.
    Hoshino H.
    Retrovirology, 5 (1)